Ole V Gjoerup (Ole Gjoerup)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Glycemic Control

Radical Prostatectomy

Circulating Tumor

Top Venues

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher J Sweeney, Russell Petry, Chang Xu, Merrida Childress, Jie He, David Fabrizio, Ole V Gjoerup, Samantha Morley, Timothy Catlett, Zoe June Assaf, Kobe Yuen, Matthew J Wongchenko, Kalpit Shah, Pratyush Gupta, Priti S Hegde, Lincoln W Pasquina, Sanjeev Mariathasan, Ryon P Graf, Thomas Powles
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Bruna Pellini, Russell W Madison, Merrida Childress, Shoshana T Miller, Ole V Gjoerup, Jason Cheng, Richard S P Huang, Michael Krainock, Pratyush Gupta, Wei Zou, David S Shames, Solomon Moshkevich, Marcus Ballinger, Minetta C Liu, Amanda G Young, Minu K Srivastava, Geoffrey R Oxnard, Mark A Socinski
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Liangliang Zhang, Omar Hamdani, Ole V Gjoerup, Cheryl Cho-Phan, Jeremy Snider, Emily H Castellanos, Halla Nimeiri, Garrett M Frampton, Jeffrey M Venstrom, Geoffrey R Oxnard, Samuel J Klempner, Alexa B Schrock
ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma. JCO precision oncology 6 (2022)
Hatim Husain, Dean C Pavlick, Bernard J Fendler, Russell W Madison, Brennan Decker, Ole V Gjoerup, Christine A Parachoniak, Margaret E McLaughlin-Drubin, Rachel L Erlich, Alexa B Schrock, Garrett M Frampton, Meghna Das Thakur, Geoffrey R Oxnard, Hanna Tukachinsky
Tumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples. JCO precision oncology 6 (2022)
Ryon P Graf, Virginia Fisher, Richard S P Huang, Omar Hamdani, Ole V Gjoerup, Jennifer Stanke, James Creeden, Mia A Levy, Geoffrey R Oxnard, Shilpa Gupta
Tumor Mutational Burden as a Predictor of First-Line Immune Checkpoint Inhibitor Versus Carboplatin Benefit in Cisplatin-Unfit Patients With Urothelial Carcinoma. JCO precision oncology 6 (2022)